Alto Neuroscience, Inc. Financial Flexibility Index
Alto Neuroscience, Inc. financial flexibility index. Alto Neuroscience, Inc. (ANRO) has a Financial Flexibility Index of -0.34x as of December 2025. Free cash flow of $-11.52 Million (operating CF $-11.52 Million minus capex $0.00) represents 0% of total liabilities ($33.55 Million).
Financial Flexibility Index
Free Cash Flow
Total Liabilities
Capital Expenditures
Financial Flexibility Index of Alto Neuroscience, Inc. (2021–2025)
Financial flexibility index of Alto Neuroscience, Inc. from 2021 to 2025. Historical Financial Flexibility Index trend for Alto Neuroscience, Inc. across 5 annual periods. Explore Alto Neuroscience, Inc. (ANRO) debt coverage ratio to assess how comfortably operating cash covers total debt obligations.
Alto Neuroscience, Inc. Financial Flexibility Index by Year (2021–2025)
Alto Neuroscience, Inc. financial flexibility index by year from 2021 to 2025. Year-by-year free cash flow to debt coverage for Alto Neuroscience, Inc.. For the full cash flow conversion analysis, see ANRO cash flow conversion.
| Year | Flexibility Index | Free Cash Flow (USD) | Operating CF | Total Liabilities | YoY Change |
|---|---|---|---|---|---|
| 2025 | -1.54x | $-51.74 Million | $-51.77 Million | $33.55 Million | ▲ +11.3% |
| 2024 | -1.74x | $-45.35 Million | $-47.42 Million | $26.08 Million | ▼ -734.6% |
| 2023 | -0.21x | $-32.98 Million | $-33.45 Million | $158.30 Million | ▲ +5.4% |
| 2022 | -0.22x | $-19.66 Million | $-20.39 Million | $89.26 Million | ▼ -5.9% |
| 2021 | -0.21x | $-8.58 Million | $-9.26 Million | $41.27 Million | — |